Reduced sirolimus systemic exposure and improved bioresorbable polymer properties: new allies for the treatment of patients with coronary artery disease.
Stojkovic S, Neskovic AN, Mehmedbegovic Z, Kafedzic S, Ostojic M, Nedeljkovic M, Orlic D, Ilisic B, Ilic I, Aleksic A, Cerovic M, Nikolajevic I, Vlahovic-Stipac A, Stajic Z, Putnikovic B, Hamilos M.
Stojkovic S, et al. Among authors: stajic z.
Fundam Clin Pharmacol. 2015 Feb;29(1):95-105. doi: 10.1111/fcp.12092. Epub 2014 Dec 11.
Fundam Clin Pharmacol. 2015.
PMID: 25223651